Mersana Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2025 to a ratio of 305.81, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2025. Average receivable collection period, for the Mersana Therapeutics Inc in Sep 30 2025 quarter, has decreased to 1 days, compared to 3 days, in the Jun 30 2025 quarter.

If we take a look into Healthcare sector 372 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2025 from 2426 to 2506.

What is Receivable Turnover Ratio?
What is Mersana Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRSN Receivables Turnover Ratio	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Receivable Change	-83.2 %	-83.06 %	-	-	-
Y / Y Revenue Change	-12.61 %	33.28 %	-70.21 %	52.89 %	63.65 %
Receivable Turnover Ratio (TTM)	305.81	109.85	52.93	63.03	54.22
MRSN's Total Ranking	# 2506	# 2426	# 229	# 2445	# 2445
Accounts Receivable average collection period days	1	3	7	6	7
Seq. Receivable Change	-36.84 %	-	-	-	-36.31 %
Seq. Revenue Change	260.24 %	10.97 %	-83.17 %	29.87 %	449.41 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 111
Healthcare Sector	# 373
Overall Market	# 2506

Receivable Turnover Ratio Statistics
High	Average	Low
0.33	0.1	-0
(Sep 30 2025)

MRSN Company Profile • Back to MRSN Efficiency Comparisons • Compare MRSN Receivables Turnover Ratio to its Competitors

Financial Statements
Mersana Therapeutics Inc 's Accounts Receivable	$ 0 Millions	Visit MRSN's Balance sheet
Mersana Therapeutics Inc 's Sales TTM	$ 33 Millions	Visit MRSN's Income Statement
Sources of MRSN's Revenues		Visit MRSN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MRSN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MRSN's Growth Rates	MRSN's Roa	MRSN's Inventory Turnover Ratio	MRSN's Dividend Comparisons
MRSN's Profitability Ratios	MRSN's Roi	MRSN's Asset Turnover Ratio	MRSN's Dividend Growth
MRSN's Valuation Ratios	MRSN's Roe	MRSN's Financial Strength Ratios	MRSN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2025	Receivable at quarter ending Sep 30 2025
Zeo Scientifix Inc	378.11	$ 5.199 Millions	$ 0.014 Millions
Bausch Health Companies Inc	342.87	$ 10,029.000 Millions	$ 29.250 Millions
Iqvia Holdings Inc	342.02	$ 15,904.000 Millions	$ 46.500 Millions
Mersana Therapeutics inc	305.81	$ 33.180 Millions	$ 0.109 Millions
Ginkgo Bioworks Holdings Inc	214.62	$ 180.606 Millions	$ 0.842 Millions
Fortress Biotech Inc	206.05	$ 60.786 Millions	$ 0.295 Millions
Arcus Biosciences Inc	192.00	$ 240.000 Millions	$ 1.250 Millions
Arrowhead Pharmaceuticals Inc	175.66	$ 829.448 Millions	$ 4.722 Millions
Prime Medicine Inc	174.51	$ 5.977 Millions	$ 0.034 Millions
Protagonist Therapeutics inc	164.12	$ 209.217 Millions	$ 1.275 Millions
Assembly Biosciences Inc	163.12	$ 37.191 Millions	$ 0.228 Millions
Earth Science Tech Inc	140.76	$ 32.844 Millions	$ 0.233 Millions
Nakamoto Inc	136.72	$ 1.980 Millions	$ 0.014 Millions
Sbc Medical Group Holdings Incorporated	115.24	$ 285.167 Millions	$ 2.474 Millions
Logicmark Inc	107.06	$ 10.609 Millions	$ 0.099 Millions
Aclaris Therapeutics Inc	82.63	$ 15.741 Millions	$ 0.191 Millions
Monte Rosa Therapeutics Inc	81.44	$ 181.538 Millions	$ 2.229 Millions
Longduoduo Co Ltd	73.11	$ 4.152 Millions	$ 0.057 Millions
Atara Biotherapeutics Inc	69.93	$ 214.503 Millions	$ 3.068 Millions
Eyepoint Inc	62.29	$ 42.340 Millions	$ 0.680 Millions
Stoke Therapeutics Inc	59.76	$ 205.632 Millions	$ 3.441 Millions
Agenus Inc	55.26	$ 106.829 Millions	$ 1.933 Millions
Brookdale Senior Living Inc	55.20	$ 3,220.921 Millions	$ 58.351 Millions
Airsculpt Technologies Inc	53.94	$ 157.554 Millions	$ 2.921 Millions
Cytomx Therapeutics Inc	53.12	$ 113.631 Millions	$ 2.139 Millions
Lifevantage Corp	50.18	$ 227.759 Millions	$ 4.539 Millions
Humacyte Inc	46.85	$ 22.958 Millions	$ 0.490 Millions
Agape Atp Corporation	45.47	$ 1.485 Millions	$ 0.033 Millions
Fortrea Holdings Inc	45.15	$ 2,759.900 Millions	$ 61.125 Millions

Date modified: 2026-08-29T17:41:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.